Close

Rating History for BridgeBio Pharma (BBIO) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for BBIO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/17/2023 Paul Choi Maintain Buy
(N/A)		 50.00
(29.00)		  
 		   Details